Horizon Discovery Inks Additional Licensing Pacts with U of Washington
December 14, 2009
Horizon Discovery Inks Additional Licensing Pacts with U of Washington
By a GenomeWeb staff reporter
Horizon will use UW gene-engineering tech to develop mammalian cell lines for bioproduction and pluripotent human stem cells for predicting cancer drug responses.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.